Mediaiplus (메디아이플러스)
Seongnam-si, South Korea
Mediaiplus is a B2B digital health venture specializing in clinical trial support. It provides customized clinical trial protocols and curated clinical trial data to assist clients in launching drug development projects. Utilizing Artificial Intelligence and Natural Language Processing, the company aims to revolutionize pre-clinical and clinical trial processes. Their platform helps researchers and corporations find Contract Research Organizations (CROs) more efficiently and expedites the clinical preparation process. By visualizing and tracking global clinical trial data, Mediaiplus enables actionable insights, ultimately helping new treatments reach patients faster.
Company Info
- Founded
- 2019
- Website
- mediaiplus.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Mediaiplus (메디아이플러스)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.